Common side effects include: Injection site reactions mild pain, redness, swelling, or bruising at the injection site, typically resolving within a few days Headache usually transient and manageable with standard analgesia Nausea or dizziness particularly in the initial treatment phase Skin reactions including itching, mild rash, or acneiform eruptions Temporary urine discolouration red or orange urine is harmless and expected Diarrhoea or flushing usually mild and self-limiting In patients with severe megaloblastic anaemia, low potassium levels (hypokalaemia) may occur during initial intensive treatment, but this is uncommon in routine maintenance therapy
It does this without raising IGF-1 levels, without affecting insulin sensitivity, and without promoting tissue growth beyond fat metabolism
However, it is available for purchase and use for wellness purposes through compounding pharmacies with a doctor's prescription
BPC-157 may reduce pain and improve function by enhancing blood supply to the peripheral labrum and reducing associated inflammation
Lab-Tested for Purity Verified for accuracy and consistency in research applications
)
